CVRx Announces Increased Inpatient Payment for Barostim Procedure
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that […]
Agrify Reminds Stockholders to Vote Before the Proxy Voting Deadline for the Upcoming Annual Meeting of Stockholders
BILLERICA, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), the most innovative provider of advanced […]
Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. […]
MediWound to Report Second Quarter 2024 Financial Results
YAVNE, Israel, Aug. 02, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for […]
The Ensign Group Grows in Colorado
SAN JUAN CAPISTRANO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group […]
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
Funding Extends Company’s Cash Runway into Second Quarter 2025, which is beyond the Anticipated Timing for SHIELD II Top-line Results […]
European Wax Center, Inc. to Report Second Quarter Fiscal Year 2024 Financial Results on August 14th
PLANO, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) — European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and […]
Cavco Industries Reports Fiscal 2025 First Quarter Results
PHOENIX, Aug. 01, 2024 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) (“we,” “our,” the “Company” or “Cavco”) today announced […]
Jet.AI Unveils Advanced AI Technology DynoFlight Platform
LAS VEGAS, Aug. 01, 2024 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation […]
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
ATLANTA, Aug. 01, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on […]
